HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:

GSK Plans International Expansion Of Stiefel's Dermatology Business

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

As part of a "multi-pronged" strategy for leveraging its acquisition of Stiefel Laboratories, GlaxoSmithKline plans to introduce the Coral Gables, Fla. firm's Rx and nonprescription dermatology brands to a global audience

You may also be interested in...



MaxClarity Delivers Anti-Acne Actives Via Penetration-Enhancing Foam

Stiefel Laboratories differentiates its MaxClarity Acne Management System with VersaFoam technology to deliver active ingredients in foam

MaxClarity Delivers Anti-Acne Actives Via Penetration-Enhancing Foam

Stiefel Laboratories differentiates its MaxClarity Acne Management System with VersaFoam technology to deliver active ingredients in foam

GSK Iso-Active Toothpastes Employ Double Foam, Claim Triple Efficacy

GlaxoSmithKline is replacing the conventional toothpaste tube with a canister like those used for shaving products to deliver its new Aquafresh and Sensodyne products with "twice the foam volume as ordinary toothpaste.
Table

View full table

Related Content

HBW Insight HBW Insight
Tags:
UsernamePublicRestriction

Register

RS016728

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By